Annotation Detail

Information
Associated Genes
CD274
Associated Variants
CD274 EXPRESSION
CD274 EXPRESSION
Associated Disease
lung non-small cell carcinoma
Source Database
CIViC Evidence
Description
Meta-Analysis of PD-L1 (CD274) Expression Status in 914 patients (7 studies) and response to PD-1/PD-L1 monoclonal antibodies. Patients with PD-L1 positive tumors (PD-L1 tumor cell staining ≥1%), had a significantly higher ORR, compared to patients with PD-L1 negative tumors (OR: 2.44; 95% CIs: 1.61-3.68).
Variant Origin
N/A
Variant Origin
N/A
Evidence URL
https://civic.genome.wustl.edu/links/evidence_items/1167
Gene URL
https://civic.genome.wustl.edu/links/genes/11335
Variant URL
https://civic.genome.wustl.edu/links/variants/276
Rating
4
Evidence Type
Predictive
Disease
Lung Non-small Cell Carcinoma
Evidence Direction
Supports
Drug
Atezolizumab,Nivolumab,Avelumab,Pembrolizumab
Evidence Level
B
Clinical Significance
Sensitivity/Response
Pubmed
26918451
Drugs
Drug NameSensitivitySupported
AvelumabSensitivitytrue
AtezolizumabSensitivitytrue
PembrolizumabSensitivitytrue
NivolumabSensitivitytrue